- Report
- June 2023
- 132 Pages
Global
From €938EUR$950USD£782GBP
- Webinar
- May 2023
- 60 Minutes
Global
From €148EUR$150USD£123GBP
- Report
- July 2022
- 54 Pages
Global
From €3457EUR$3,500USD£2,881GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£700GBP
- Report
- May 2022
- 36 Pages
Global
From €2469EUR$2,500USD£2,058GBP
- Report
- May 2022
- 52 Pages
Global
From €2469EUR$2,500USD£2,058GBP
- Report
- May 2022
- 57 Pages
Global
From €2469EUR$2,500USD£2,058GBP
- Webinar
- February 2022
- 60 Minutes
United States
From €148EUR$150USD£123GBP
- Book
- January 2022
- 504 Pages
- Webinar
- December 2021
- 90 Minutes
Global
From €148EUR$150USD£123GBP
- Webinar
- December 2021
- 90 Minutes
Global
From €193EUR$195USD£161GBP
- Webinar
- December 2021
- 60 Minutes
Global
From €188EUR$190USD£156GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more